the best shares to buy now

European stocks ended higher Friday, getting a boost from health-care shares, a move that solidified a rise for blue-chip equities for a third consecutive week.

The Stoxx Europe 600
SXXP, +0.18%
rose 0.2% to end at 342.45, but it searched for firm footing throughout the session. Health-care shares put in the strongest performance while the financial and oil and gas were the two sectors that finished lower.

the best shares to buy now: Estee Lauder Companies, Inc. (The)(EL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The 20 stocks meeting those requirements are: Ralph Lauren (RL), Time Warner(TWX), Twenty-First Century Fox(FOXA), PepsiCo(PEP), Estee Lauder(EL), Tesoro(TSO), XL(XL), Ameriprise Financial,(AMP), Unum(UNM), Merck(MRK), AbbVie(ABBV), Gilead Sciences(GILD), General Dynamics(GD), Alaska Air(ALK), United Continental(UAL), Delta Air Lines(DAL), Oracle(ORCL), eBay(EBAY), Apple(AAPL), and Centurylink(CTL).

  • [By WWW.THESTREET.COM]

    GLP’s customers include Walmart (WMT) , Unilever (UL) , JD.com (JD) , Adidas (ADDYY) , Estee Lauder (EL) and L’Oreal (LRLCY) .

    The S$3.38 offer price represents 81% premium over its 12-month volume weighted average price and a 25% premium over its last full trading day before the announcement.

the best shares to buy now: NCI, Inc.(NCIT)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Information technology company NCI Inc (NASDAQ: NCIT) reported its $283 million sale to H.I.G. Capital Management for $20 per share in cash.

    9. Allied World Assurance

    The insurance firms of Allied World Assurance Company Hldgs Ltd (NYSE: AWH) and Fairfax Financial extended the offering period for purchase of outstanding Allied World shares from June 30 to July 5.

the best shares to buy now: Roche Holding AG (RHHBY)

Advisors’ Opinion:

  • [By Keith Speights]

    Eisai (NASDAQOTH:ESALY), Novo Nordisk (NYSE:NVO), and Roche Holding Ltd. (NASDAQOTH:RHHBY) fit that description well. Each of these companies markets obesity drugs, but each also sells a broad array of other products with multiple pipeline candidates potentially on the way. Here’s why Eisai, Novo Nordisk, and Roche rank as the three best obesity-drug stocks to buy in 2017.

  • [By SEEKINGALPHA.COM]

    Keytruda is also picking up indications, trading up Thursday on news of a new FDA approval in front line lung cancer treatment (not a big surprise, but there was some doubt). Some adverse news on Roche’s (OTCQX:RHHBY) I-O competitor Tecentriq in bladder cancer led IBD to publish this:

  • [By SEEKINGALPHA.COM]

    So yesterday we devoted 2/3 of the digest to immune checkpoint inhibitors from Merck (NYSE:MRK) and Roche (OTCQX:RHHBY). Today we have yet more ground to cover in this space!

  • [By SEEKINGALPHA.COM]

    Medtronic operates both in the therapeutic and diagnostic medical markets throughout the world; the company’s varied product lines face a vast combination of competitors, ranging from large manufacturers with multiple business lines (exemplified by Johnson & Johnson) to smaller manufacturers offering a limited selection of products, like Insulet (NASDAQ:PODD). Other notable competitors include Abbott Labs (NYSE:ABT), C.R. Bard (NYSE:BCR), Baxter (NYSE:BAX), LivaNova (NASDAQ:LIVN), Roche (OTCQX:RHHBY), DexCom (NASDAQ:DXCM) and Tandem (NASDAQ:TNDM).

  • [By SEEKINGALPHA.COM]

    As the graphic below shows, ImmunoGen’s product pipeline is potentially significant. Furthermore, it is impressive to see the involvement and partnerships in these early stage compounds by some of the world’s leading pharmaceutical and biotech companies. This includes firms like Amgen (NASDAQ:AMGN), Roche (OTCQX:RHHBY), Bayer (OTCPK:BAYRY), Sanofi (NYSE:SNY), Eli Lilly (NYSE:LLY), and Novartis (NYSE:NVS).

the best shares to buy now: Energy XXI Ltd.(EXXI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Energy XXI Ltd (NASDAQ: EXXI) were down 72 percent to $0.181 after the company announced that it and some of its subsidiaries have entered into a Restructuring Support Agreement (RSA) with holders of more than 63 percent of its secured second lien 11.0 percent notes. Energy XXI added that in order to implement the terms of the RSA, it has commenced cases under Chapter 11 of the Bankruptcy Code.

Leave a Reply

Your email address will not be published. Required fields are marked *